‘Auvi-Q’ Allergic Reaction Injectors Recalled

Pharmaceutical company Sanofi is recalling all of its injectors used to treat severe allergic reactions.

The French drug and vaccine maker, whose injectors compete with Mylan’s EpiPen, is recalling all Auvi-Q injections currently on the U.S. market, which is about 490,000 packs, ABC reports, over concerns that they may not administer the correct amount of the drug.

Sanofi said it has received 26 reports of problems with the injectors, none of which resulted in the patient’s death. About 200,000 people in the United States use Sanofi’s product.